Synkrino Biotherapeutics

C/O Citris Foun, UC Berkeley 450 Sutardja Dai Hall


Developer of novel therapeutics designed to treat patients with diseases driven by the immune system and inflammation. The company’s therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.